Increased inflammatory signaling and lethality of influenza h1n1 by nuclear thioredoxin-1

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Go, Young Mi ^a   Kang, Sang Moo ^b   Roede, James R ^a   Orr, Michael ^a   Jones, Dean P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; THIOREDOXIN 1; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; CYTOKINE; GLUCOCORTICOID; MESSENGER RNA; THIOREDOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; INFLUENZA A (H1N1); LETHALITY; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; THYMOCYTE; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE; UPREGULATION; WEIGHT REDUCTION; WILD TYPE; ANIMAL; BLOOD; C57BL MOUSE; CELL NUCLEUS; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLAMMATION; INFLUENZA; INFLUENZA VIRUS A H1N1; METABOLISM; MORTALITY; ORTHOMYXOVIRUS INFECTION; OXIDATION REDUCTION REACTION; PATHOLOGY; PHYSIOLOGY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; VIROLOGY;

MUS; MUS MUSCULUS; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL NUCLEUS; CYTOKINES; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; GLUTATHIONE DISULFIDE; HUMANS; INFLAMMATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-KAPPA B; NUCLEAR LOCALIZATION SIGNALS; ORTHOMYXOVIRIDAE INFECTIONS; OXIDATION-REDUCTION; PROTEIN TRANSPORT; RNA, MESSENGER; SIGNAL TRANSDUCTION; THIOREDOXINS; WEIGHT LOSS;

EID: 79954501342     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018918     Document Type: Article

References (60)

1. Go YM, Jones DP, (2010) Redox control systems in the nucleus: mechanisms and functions. Antioxid Redox Signal 13: 489-509.
2. Go YM, Park H, Koval M, Orr M, Reed M, et al. (2010) A key role for mitochondria in endothelial signaling by plasma cysteine/cystine redox potential. Free Radic Biol Med 48: 275-283.
3. Go YM, Ziegler TR, Johnson JM, Gu L, Hansen JM, et al. (2007) Selective protection of nuclear thioredoxin-1 and glutathione redox systems against oxidation during glucose and glutamine deficiency in human colonic epithelial cells. Free Radic Biol Med 42: 363-370.
4. Harper R, Wu K, Chang MM, Yoneda K, Pan R, et al. (2001) Activation of nuclear factor-kappa b transcriptional activity in airway epithelial cells by thioredoxin but not by N-acetyl-cysteine and glutathione. Am J Respir Cell Mol Biol 25: 178-185.
5. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, et al. (1999) Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem 274: 27891-27897.
6. Toledano MB, Leonard WJ, (1991) Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci U S A 88: 4328-4332.
7. Makino Y, Yoshikawa N, Okamoto K, Hirota K, Yodoi J, et al. (1999) Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J Biol Chem 274: 3182-3188.
8. Okamoto K, Tanaka H, Ogawa H, Makino Y, Eguchi H, et al. (1999) Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 274: 10363-10371.
9. Abate C, Patel L, Rauscher FJ 3rd, Curran T, (1990) Redox regulation of fos and jun DNA-binding activity in vitro. Science 249: 1157-1161.
10. Devary Y, Gottlieb RA, Lau LF, Karin M, (1991) Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 11: 2804-2811.
11. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, et al. (1997) AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci U S A 94: 3633-3638.
12. Hansen JM, Watson WH, Jones DP, (2004) Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol Sci 82: 308-317.
13. Kim YC, Yamaguchi Y, Kondo N, Masutani H, Yodoi J, (2003) Thioredoxin-dependent redox regulation of the antioxidant responsive element (ARE) in electrophile response. Oncogene 22: 1860-1865.
14. Ema M, Hirota K, Mimura J, Abe H, Yodoi J, et al. (1999) Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J 18: 1905-1914.
15. Ravi D, Muniyappa H, Das KC, (2005) Endogenous thioredoxin is required for redox cycling of anthracyclines and p53-dependent apoptosis in cancer cells. J Biol Chem 280: 40084-40096.
16. Ueno M, Matsutani Y, Nakamura H, Masutani H, Yagi M, et al. (2000) Possible association of thioredoxin and p53 in breast cancer. Immunol Lett 75: 15-20.
17. Kabe Y, Ando K, Hirao S, Yoshida M, Handa H, (2005) Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7: 395-403.
18. Matthews JR, Kaszubska W, Turcatti G, Wells TN, Hay RT, (1993) Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B. Nucleic Acids Res 21: 1727-1734.
19. Powis G, Mustacich D, Coon A, (2000) The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med 29: 312-322.
20. Sen R, Baltimore D, (1986) Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47: 921-928.
21. Hansen JM, Moriarty-Craige S, Jones DP, (2007) Nuclear and cytoplasmic peroxiredoxin-1 differentially regulate NF-kappaB activities. Free Radic Biol Med 43: 282-288.
22. Ahn KS, Aggarwal BB, (2005) Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann N Y Acad Sci 1056: 218-233.
23. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, et al. (2009) Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A 106: 3455-3460.
24. Brydon EW, Morris SJ, Sweet C, (2005) Role of apoptosis and cytokines in influenza virus morbidity. FEMS Microbiol Rev 29: 837-850.
25. To KK, Hung IF, Li IW, Lee KL, Koo CK, et al. (2010) Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 50: 850-859.
26. Grippo JF, Holmgren A, Pratt WB, (1985) Proof that the endogenous, heat-stable glucocorticoid receptor-activating factor is thioredoxin. J Biol Chem 260: 93-97.
27. Makino Y, Okamoto K, Yoshikawa N, Aoshima M, Hirota K, et al. (1996) Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system. J Clin Invest 98: 2469-2477.
28. Grippo JF, Tienrungroj W, Dahmer MK, Housley PR, Pratt WB, (1983) Evidence that the endogenous heat-stable glucocorticoid receptor-activating factor is thioredoxin. J Biol Chem 258: 13658-13664.
29. Psarra AM, Hermann S, Panayotou G, Spyrou G, (2009) Interaction of mitochondrial thioredoxin with glucocorticoid receptor and NF-kappaB modulates glucocorticoid receptor and NF-kappaB signalling in HEK-293 cells. Biochem J 422: 521-531.
30. Cifone MG, Migliorati G, Parroni R, Marchetti C, Millimaggi D, et al. (1999) Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood 93: 2282-2296.
31. Zacharchuk CM, Mercep M, Chakraborti PK, Simons SS Jr, Ashwell JD, (1990) Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic. J Immunol 145: 4037-4045.
32. Marques AH, Silverman MN, Sternberg EM, (2009) Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics. Ann N Y Acad Sci 1179: 1-18.
33. de Oliveira-Marques V, Cyrne L, Marinho HS, Antunes F, (2007) A quantitative study of NF-kappaB activation by H2O2: relevance in inflammation and synergy with TNF-alpha. J Immunol 178: 3893-3902.
34. Gasdaska JR, Kirkpatrick DL, Montfort W, Kuperus M, Hill SR, et al. (1996) Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73→Ser mutation. Biochem Pharmacol 52: 1741-1747.
35. Watson WH, Pohl J, Montfort WR, Stuchlik O, Reed MS, et al. (2003) Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J Biol Chem 278: 33408-33415.
36. Jones DP, Liang Y, (2009) Measuring the poise of thiol/disulfide couples in vivo. Free Radic Biol Med 47: 1329-1338.
37. Go YM, Gipp JJ, Mulcahy RT, Jones DP, (2004) H2O2-dependent activation of GCLC-ARE4 reporter occurs by mitogen-activated protein kinase pathways without oxidation of cellular glutathione or thioredoxin-1. J Biol Chem 279: 5837-5845.
38. Quan FS, Vunnava A, Compans RW, Kang SM, (2010) Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice. PLoS One 5: e9161.
39. Takagi Y, Mitsui A, Nishiyama A, Nozaki K, Sono H, et al. (1999) Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci U S A 96: 4131-4136.
40. Malik G, Gorbounov N, Das S, Gurusamy N, Otani H, et al. (2006) Ischemic preconditioning triggers nuclear translocation of thioredoxin and its interaction with Ref-1 potentiating a survival signal through the PI-3-kinase-Akt pathway. Antioxid Redox Signal 8: 2101-2109.
41. Xanthoudakis S, Curran T, (1992) Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 11: 653-665.
42. Hayashi S, Hajiro-Nakanishi K, Makino Y, Eguchi H, Yodoi J, et al. (1997) Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res 25: 4035-4040.
43. Schroeder P, Popp R, Wiegand B, Altschmied J, Haendeler J, (2007) Nuclear redox-signaling is essential for apoptosis inhibition in endothelial cells-important role for nuclear thioredoxin-1. Arterioscler Thromb Vasc Biol 27: 2325-2331.
44. Watson WH, Jones DP, (2003) Oxidation of nuclear thioredoxin during oxidative stress. FEBS Lett 543: 144-147.
45. Spielberger JC, Moody AD, Watson WH, (2008) Oxidation and nuclear localization of thioredoxin-1 in sparse cell cultures. J Cell Biochem 104: 1879-1889.
46. Forneris F, Binda C, Vanoni MA, Mattevi A, Battaglioli E, (2005) Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process. FEBS Lett 579: 2203-2207.
47. Rowe LA, Degtyareva N, Doetsch PW, (2008) DNA damage-induced reactive oxygen species (ROS) stress response in Saccharomyces cerevisiae. Free Radic Biol Med 45: 1167-1177.
48. Libermann TA, Baltimore D, (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10: 2327-2334.
49. Lenardo MJ, Baltimore D, (1989) NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58: 227-229.
50. Rota M, Boni A, Urbanek K, Padin-Iruegas ME, Kajstura TJ, et al. (2005) Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circ Res 97: 1332-1341.
51. Schilling G, Savonenko AV, Klevytska A, Morton JL, Tucker SM, et al. (2004) Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice. Hum Mol Genet 13: 1599-1610.
52. Dai S, He Y, Zhang H, Yu L, Wan T, et al. (2009) Endothelial-specific expression of mitochondrial thioredoxin promotes ischemia-mediated arteriogenesis and angiogenesis. Arterioscler Thromb Vasc Biol 29: 495-502.
53. He M, Cai J, Go YM, Johnson JM, Martin WD, et al. (2008) Identification of thioredoxin-2 as a regulator of the mitochondrial permeability transition. Toxicol Sci 105: 44-50.
54. Nakamura H, Tamura S, Watanabe I, Iwasaki T, Yodoi J, (2002) Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia. Immunol Lett 82: 165-170.
55. Zhang H, Luo Y, Zhang W, He Y, Dai S, et al. (2007) Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions. Am J Pathol 170: 1108-1120.
56. Rajasekaran NS, Connell P, Christians ES, Yan LJ, Taylor RP, et al. (2007) Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell 130: 427-439.
57. Zhang X, Min X, Li C, Benjamin IJ, Qian B, et al. (2010) Involvement of reductive stress in the cardiomyopathy in transgenic mice with cardiac-specific overexpression of heat shock protein 27. Hypertension 55: 1412-1417.
58. Goldsack NR, Allen S, Lipman MC, (2003) Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy. Sex Transm Infect 79: 337-338.
59. Powis G, Kirkpatrick L, (2004) Hypoxia inducible factor-1alpha as a cancer drug target. Mol Cancer Ther 3: 647-654.
60. Jones DP, Mody VC Jr, Carlson JL, Lynn MJ, Sternberg P Jr, (2002) Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med 33: 1290-1300.